Velocity’s research site in Cincinnati was founded by Dr. Gregory Gottschlich in 1988 as New Horizons Clinical Research and acquired by Velocity in 2017. Dr. Gottschlich, who is Board Certified in Internal Medicine, established the research center to handle the growing need for clinical trials in his specialty. Dr. Gottschlich was instrumental in recognizing the need to join together geographically dispersed research sites and took leadership in achieving that goal. Our Cincinnati site offers a wide range of expertise in Respiratory, Immunology, Internal medicine, Rheumatology and Orthopedic indications, including allergy, asthma, COPD, hypertension, CAD, hyperlipidemia, diabetes, osteoarthritis, musculoskeletal disorders, gout, and chronic pain. In addition, this site has experience conducting studies in vaccines and rare diseases.
The Cincinnati site has a large and diverse study participant population, including pediatric and geriatric patients from a range of ethnic backgrounds. An expansive patient database enhances recruitment efforts. Located in Blue Ash, a suburb of Cincinnati, just 15 minutes north of downtown Cincinnati and only 30 minutes from the Northern Kentucky/Cincinnati International Airport, this site has easy access to main highways. The building is just across the street from a large park and less than two miles from two area hospitals. Ample free parking is on site. With more than 7,200 square-feet of dedicated research space, they can efficiently and effectively conduct multiple concurrent studies.
All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Velocity Cincinnati team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.
